EC Number   |
Protein Variants |
Reference |
|---|
   3.6.4.10 | A107N |
the mutation increases ATPase activity about 5fold compared to the wild type |
757734 |
| 3.6.4.10 | A116N |
reduced affinity to co-chaperone Hop in the presence of ATP analogue AMPPNP |
699538 |
| 3.6.4.10 | A17V |
nucleotide-binding domain mutant |
695861 |
| 3.6.4.10 | C63A |
the ATPase activity displayed by the unmodified ATPase domain Kar2 is fully maintained when Cys63 is replaced with Ala |
757432 |
| 3.6.4.10 | C63E |
the mutant shows limited ATPase activity |
757432 |
| 3.6.4.10 | C63F |
the mutation leads to loss of ATPase activity. The mutation supports an enhanced viability during oxidative stress associated with the oxidized ATPase domain Kar2 |
757432 |
| 3.6.4.10 | C63H |
the mutation supports an enhanced viability during oxidative stress associated with the oxidized ATPase domain Kar2 |
757432 |
| 3.6.4.10 | C63N |
the mutant shows limited ATPase activity |
757432 |
| 3.6.4.10 | C63P |
the mutation supports an enhanced viability during oxidative stress associated with the oxidized ATPase domain Kar2 |
757432 |
| 3.6.4.10 | C63V |
the ATPase activity displayed by the unmodified ATPase domain Kar2 is fully maintained when Cys63 is replaced with Val |
757432 |
